The United States is on track to invest close to $1 trillion in artificial intelligence (AI) by the end of 2026, with technology giants pouring billions into data centers, computing infrastructure, and research. However, a new analysis by the McKinsey Global Institute (MGI) highlights a significant disconnect: this unprecedented AI spending has yet to trigger a widespread industrial revival across the US economy.
The report, published on October 21, 2026, suggests that while America is a dominant force in AI infrastructure and innovation, this investment has not translated into a comparable expansion of factories, industrial equipment, or overall productive capacity.
The Scale of US AI Investment
Over the past two decades, US technology companies, particularly hyperscalers in cloud computing, have dramatically increased their capital expenditure and research and development (R&D) investments. McKinsey notes a 50-fold increase from roughly $15 billion in 2005 to an estimated $750 billion by 2025, projected to reach nearly $1 trillion by 2026.
This substantial investment targets advanced chips, computing infrastructure, and AI capabilities crucial for the burgeoning demand for artificial intelligence. Yet, the MGI emphasizes that this surge in AI-related spending does not automatically translate into broader productive investment across all sectors of the economy.
Why Industrial Growth Lags
Productive investment, encompassing factories, machinery, industrial equipment, and infrastructure, has shown little change as a share of US Gross Domestic Product (GDP). McKinsey's analysis reveals a 6% decline in investment in US factory structures by late 2025, following a peak in 2024, while general industrial equipment spending remained largely flat.
The momentum for reshoring manufacturing operations back to the US has also plateaued in investment data. This is critical given national efforts to reduce dependence on overseas manufacturing for essential goods like semiconductors and pharmaceuticals. Addressing America's most critical import dependencies could require an additional $2 trillion in manufacturing investment, equivalent to approximately 6% of US GDP.
Major Cost Disadvantages for US Manufacturing
One primary obstacle to a broader American industrial resurgence is the high cost of manufacturing domestically. Excluding subsidies, building semiconductor facilities in the US can be 40% more expensive than in competitive locations, and pharmaceutical production costs can be 60% higher.
McKinsey identifies two key reasons for this disparity:
- Higher Construction Costs and Longer Project Timelines: Industrial facility construction in the US is significantly more expensive and time-consuming than in many Asian economies. Costs can be double, and projects may take twice as long to complete, tying up capital for extended periods.
- Higher Labor Costs Without Corresponding Productivity: US labor costs are two to five times higher than in China or Taiwan. Historically justified by greater worker productivity, this advantage has diminished in comparable industrial settings. For instance, Taiwanese engineers in advanced semiconductor facilities are about 25% more productive than their US counterparts, despite American wages being 2.7 times higher.
The China Contrast
The MGI report highlights a stark contrast with China, which adds approximately $4.4 trillion in net productive assets annually – roughly four times the US amount. This gap underscores that industrial competitiveness relies not only on technological innovation but also on the ability to scale manufacturing, manage supply chains, and expand physical production capacity.
Technology as a Solution for Competitiveness
Despite the challenges, McKinsey suggests technology could help mitigate America's manufacturing cost disadvantage. Adopting modular and off-site construction methods could reduce project timelines by 50% and capital costs by 10-20%. AI-driven production systems and robotics could also boost labor productivity and operational efficiency, offsetting some higher wage costs.
A combination of these measures could close half to two-thirds of the US manufacturing cost gap. Beyond technology, American manufacturers can compete through superior product quality, innovation, brand value, customer proximity, and specialized services, particularly in high-value sectors like complex drug therapies.
Rethinking US Industrial Policy
McKinsey argues that the US government cannot realistically subsidize or protect every manufacturing industry. Instead, policymakers should prioritize sectors where reliance on overseas suppliers creates significant economic or national security risks. The analysis points to roughly 25% of imported manufactured goods as America's industrial Achilles' heel, identifying products critical for national security, vulnerable to concentrated supply chains, or sourced from distant trading partners.